• Explore /
  • Poster
  • / Obinutuzumab short-duration infusion (SDI) in previously untreated advanced follicular lymphoma: Results from the end of induction analysis of the phase IV GAZELLE study.

Obinutuzumab short-duration infusion (SDI) in previously untreated advanced follicular lymphoma: Results from the end of induction analysis of the phase IV GAZELLE study.

Abstract Video & Slides Poster

Authors

null

Miguel Angel A. Canales Albendea

Hospital Universitario La Paz, Madrid, Spain

Miguel Angel A. Canales Albendea , Thomas A. Buchholz , Koji Izutsu , Takayuki Ishikawa , Laura Maria Fogliatto , Ekaterina Vorozheikina , Dirk Klingbiel , Sunny Pokala , Monique Tomiczek , Joana Parreira , Kai Hübel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies

Sub Track

Non-Hodgkin Lymphoma

Clinical Trial Registration Number

NCT03817853

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 7545)

DOI

10.1200/JCO.2021.39.15_suppl.7545

Abstract #

7545

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Tina Nielsen

First Author: William Townsend

First Author: Eliza Anne Hawkes

First Author: Christopher Flowers